Skip to main content

COVID-19 Response

We strongly believe that while intellectual property rights can often serve to incentivize the creation of new products, such rights should not become a barrier to addressing widespread, urgent and essential health-related needs. To address the global COVID-19 pandemic, we are each implementing technology transfer strategies to allow for and incentivize rapid utilization of our available technologies that may be useful for preventing, diagnosing and treating COVID-19 infection during the pandemic. To achieve our common goal, we each individually commit to the following guidelines:

  1. We are committed to implementing COVID-19 patenting and licensing strategies that are consistent with our goal of facilitating rapid global access. For most types of technologies, this includes the use of rapidly executable non-exclusive royaltyfree licenses to intellectual property rights that we have the right to license, for the purpose of making and distributing products to prevent, diagnose and treat COVID-19 infection during the pandemic and for a short period thereafter. In return for these royalty-free licenses, we are asking the licensees for a commitment to distribute the resulting products as widely as possible and at a low cost that allows broad accessibility during the term of the license.
  2. We are committed to making vigorous efforts to achieve alignment among all stakeholders in our intellectual property, including research sponsors, to facilitate broad and rapid access to technologies that have been requested to address the COVID-19 pandemic.
  3. We are committed to making any technology transfer transactions related to addressing the COVID-19 pandemic our first priority, and to minimizing any associated administrative burdens.
Signatories:

Harvard University
Massachusetts Institute of Technology
Stanford University
Yale University

If your Institution would like to adopt the COVID-19 Technology Access Framework, please make a public announcement to your community regarding your endorsement and post the framework in its entirety. Please contact Michelle McQueen (michelle.mcqueen@yale.edu) to have your Institution added to the list of signatories.

All media/press inquiries can be directed to Michelle McQueen (michelle.mcqueen@yale.edu)

Any questions related to COVID-19 technology licensing may be directed to OfficeofCooperativeResearch@yale.edu.

1. Sobetirome (and thyroid hormone) for treating ARDS

PI: Naftali Kaminski, MD
Yale OCR Contact: John Puziss, Ph.D., Yale University Office of Cooperative Research, (203) 785-6167, john.puziss@yale.edu(link sends e-mail)

2. VSV vaccine platform          

PI: John Rose, PhD
Yale OCR Contact: John Puziss, Ph.D., Yale University Office of Cooperative Research
(203) 785-6167, john.puziss@yale.edu(link sends e-mail)

3. pazopanib to treat ARDS and ALI      

PI: Dianqing (Dan) Wu, PhD
Yale OCR Contact: David Lewin, Ph.D., Yale University Office of Cooperative Research
(203) 785-6038, david.lewin@yale.edu(link sends e-mail)

4. Clevudine blocks CV-COVID-19 in vitro         

PI: Yung-Chi Cheng, PhD
Yale OCR Contact: David Lewin, Ph.D., Yale University Office of Cooperative Research

(203) 785-6038, david.lewin@yale.edu(link sends e-mail)

5. Inhibitors of Acidic Mammalian Chitinase    

PI: Jack Elias, MD
Yale OCR Contact: Christopher D. Unsworth, Ph.D., Yale University Office of Cooperative Research
(203) 785-3846, Christopher.unsworth@yale.edu(link sends e-mail)

6. PremieBreathe: Low Cost Self Sterilizing Humidified High Flow Nasal Cannula for Non-intubated COVID Patients   (link is external)    

PI: Anjelica Gonzalez, PhD
Yale OCR Contact: Richard Andersson, Yale University Office of Cooperative Research
(203) 436-3946, richard.andersson@yale.edu(link sends e-mail)

7. 3.5hr SARS-DoV-2 Spike-ECD IgG ELISA

PI: Carrie Redlich & Adam Wisnewski
Yale OCR Contact: David Lewin, Ph.D., Yale University Office of Cooperative Research
(203) 785-6038, david.lewin@yale.edu(link sends e-mail)

Conducting research on COVID-19 is critical to our efforts to fight the current pandemic. Here you will find an updated listing of funding opportunities from a variety of sources.

British Society for Antimicrobial Chemotherapy: BSAC COVID-19 Funding Call ($30,000)
  • Funding Organization’s Deadline: April 17, 2020
AXA Research Fund: Exceptional Flash Call for Proposals - Mitigating risk in the wake of the Covid-19 Pandemic ($270,000)
  • Internal Letter of Intent (Required) Deadline: April 27, 2020
  • Funding Organization's Deadline: May 7, 2020
  • Discipline/Subject Area: COVID-19; Climate & Environment; Health; New Technologies; Socio-Economics; Mid-Career Investigators
Biomedical Advanced Research and Development Authority (BARDA): BARDA BAA BAA-18-100-SOL-00003
  • Funding Organization’s Deadline: April 30, 2020
  • Discipline/Subject Area: COVID-19 
Atlas Network: COVID-19 Partner Response Fund ($30,000)
  • Funding Organization’s Deadline: April 30, 2020
  • Discipline/Subject Area:COVID-19; Policy Solutions 
Development of a rapidly deployable, minimum viable mechanical ventilator
  • Funding Organization’s Deadline: May 1, 2020 
Yale CoReCT 2020 COVID-19 Internal Pilot Awards ($50,000)
  • Funding Organization's Deadline: Will be reviewed on a rolling basis through May 17, 2020
  • Discipline/Subject Area: COVID-19; Cross-disciplinary Collaborations 
Pfizer: COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program ($250,000)
  • Funding Organization's Deadline: May 21, 2020
  • Discipline/Subject Area: COVID-19; Oncology; Quality & Process Improvement 
Pfizer Global Medical Grants COVID-19 Grants Program ($250,000)
  • Funding Organization's Deadline: May 22, 2020
  • Discipline/Subject Area: COVID-19; Independent Medical Education; Quality & Process Improvement
Patient-Centered Outcomes Research Institute (PCORI): Engagement Award Special Cycle - Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19 ($150,000)
  • Funding Organization's Deadline: May 22, 2020
  • Discipline/ Subject Area: COVID-19; Engagement of Patients in Healthcare Research
American Diabetes Association: ADA COVID-19 and Diabetes Research Award ($100,000)
  • Funding Organization's Deadline: May 22, 2020
  • Discipline/Subject Area: COVID-19; Diabetes
PCORI: COVID-19 Targeted PFA ($5,000,000)
  • Funding Organization's Deadline: May 26, 2020
  • Discipline/Subject Area: COVID-19; Comparative Clinical Effectiveness Research 
Department of Defense (DoD): W81XWH20-PRMRP-TTDA-COV CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health 2020 ($4,000,000)
  • Funding Organization’s Deadline: May 28, 2020 (Required Pre-application)
  • Discipline/Subject Area: COVID-19; Emerging Viral Diseases; Respiratory Health; Product Development 
Department of Defense (DoD): W81XWH20-PRMRP-IIRA-COV CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health 2020 ($1,600,000)
  • Funding Organization’s Deadline: May 28, 2020 (Required Pre-application)
  • Discipline/Subject Area: COVID-19; Emerging Viral Diseases; Respiratory Health 
American Lung Association: COVID-19 and Emerging Respiratory Viruses Research Award ($200,000)
  • Funding Organization's Deadline: May 30, 2020
  • Discipline/Subject Area: COVID-19; Pathobiology and Clinical Implications of SARS-CoV-2 Viral Infection 
Amazon Web Services (AWS): AWS Diagnostic Development Initiative (DDI) 2020
  • Funding Organization’s Deadline: June 1, 2020
  • Discipline/Subject Area: COVID-19; Diagnostic Solutions to Mitigate Future Outbreaks 
AHRQ: PA-20-072 Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
  • Funding Organization’s Deadline: June 1, 2020 
NIH: NIEHS RFA-ES-19-011 Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) ($275,000)
  • Funding Organization’s Deadline:June 1, 2020; July 1, 2020; August 1, 2020
  • Discipline/Subject Area:COVID-19; Environmental Exposure; Environmental Health Research
USDA Agriculture and Food Research Initiative - Foundational and Applied Science Program: Rapid Response to Novel Coronavirus (SARS-COV-2) Impacts Across Food and Agricultural Systems ($1,000,000)
  • Funding Organization's Deadline: June 4, 2020
  • Discipline/Subject Area: COVID-19; Impacts to Food Supply Chain; Economic Security
NIH: NCATS PAR-18-332 Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required) June 2020 ($9,000,000)
  • Funding Organization’s Deadline: June 5, 2020
  • Discipline/Subject Area: Repurposing Existing Therapeutics; COVID-19
NIH: PA-18-418 NIBIB Research Project Grant (R01 Clinical Trial Required)
  • Funding Organization’s Deadline: June 5, 2020; Standard R01 deadlines
  • Discipline/Subject Area: Early-Stage Clinical Trials; COVID-19 
NIH: PAR-18-530 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
  • Funding Organization’s Deadline: June 5, 2020; Standard R01 deadlines
  • Discipline/Subject Area: Translational Research; COVID-19
Department of Defense (DoD): W81XWH20-PRMRP-CTA-COV CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health 2020
  • Funding Organization's Deadline: Rolling through June 8, 2020
  • Discipline/Subject Area: COVID-19; Education Research 
Spencer Foundation: Research Grants on Education: COVID-19 Related Special Grant Cycle ($50,000)
  • Funding Organization’s Deadline: June 8, 2020 (Required Pre-application)
  • Discipline/Subject Area: COVID-19; Emerging Viral Diseases; Respiratory Health; Clinical Trials 
Pfizer Global Medical Grants: Providing Enhanced Medical Support for Patients with Primary Immunodeficiency (PI) Disorders ($250,000)
  • Funding Organization’s Deadline: June 8, 2020
  • Discipline/Subject Area: Patient-focused Programs to Support the Needs of Individuals with Primary Immunodeficiency (PI) Disorders during the COVID-19 Pandemic
NIH: NCATS PAR-18-462 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed) June 2020 ($225,000)
  • Funding Organization’s Deadline: June 16, 2020
  • Discipline/Subject Area: Repurposing Existing Therapeutics; COVID-19
NIH: PAR-20-084 NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) ($400,000)
  • Funding Organization’s Deadline: June 16, 2020
  • Discipline/Subject Area: Engineering; Physical Sciences; Biomedical Sciences; Life Sciences; COVID-19
MIT Solve Health Security and Pandemics Challenge ($10,000)
  • Funding Organization’s Deadline: June 18, 2020
NIH: NCATS PAR-17-465 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3) June 2020
  • Funding Organization’s Deadline: June 26, 2020
  • Discipline/Subject Area: Pre-clinical Studies to Repurpose Existing Therapeutics; COVID-19
NIH: NIAID RFA-AI-20-028 Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) ($3,750,000)
  • Funding Organization’s Deadline: June 29, 2020
  • Discipline/Subject Area: COVID-19; Emerging Infectious Diseases/Pathogens
BARDA Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement BAA-20-100-SOL-0002 Special Instructions 005 ($750,000)
  • Funding Organization’s Deadline: June 30, 2020
  • Discipline/Subject Area:Point-of-Care Diagnostic Assay for detection of SARS-CoV-2 virus; Diagnostic Tests for detection of COVID-19 disease; COVID-19 Vaccine; Advanced Manufacturing Technologies
U.S. Department of State: PAS-SEC-FY20- 03 U.S. Embassy Quito Funding Opportunity 2020 ($50,000)
  • Funding Organization’s Deadline: June 30, 2020
  • Discipline/Subject Area: COVID-19; Projects to Reactivate the Ecuadorian Economy and/or Support Communities
Department of Defense (DoD): W81XWH20-PRMRP-TTDA CDMRP Peer Reviewed Medical Research Program Technology/Therapeutic Development Award
  • Funding Organization’s Deadline: August 20, 2020
  • Discipline/Subject Area: Technology/Therapeutic Development; Various topics of interest including Emerging Viral Diseases
NIH: NIH PA-20-172 Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) October 2020
  • Funding Organization's Deadline: October 5, 2020; Standard R01 deadlines
  • Discipline/Subject Area: COVID-19; Health Disparities; Disaster Impact
U.S. Department of State: ND-NOFO-20- 111 COVID-19 Small Grants Program ($100,000)
  • Funding Organization's Deadline: September 30, 2020
  • Discipline/Subject Area: COVID-19; Research Collaborations between U.S. and Indian Investigators
NIH: NIH PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
  • Funding Organization’s Deadline: Rolling until February 1, 2021
  • Discipline/Subject Area: COVID-19
NIH: NIH PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
  • Funding Organization’s Deadline: Rolling
  • Discipline/Subject Area:COVID-19
Robert Wood Johnson Foundation: Pioneering Ideas: Exploring the Future to Build a Culture of Health
  • Funding Organization’s Deadline: Rolling
  • Discipline/Subject Area: Health Equity;COVID-19
NSF: 2020 NSF Rapid Response Research (RAPID) Non-medical, Non-clinical-care Grants ($200,000)
  • • Funding Organization’s Deadline: Rolling
NSF: 2020 NSF Rapid Response Research (RAPID) Advanced Cyberinfrastructure Grants ($200,000)
  • Funding Organization’s Deadline: Rolling
NIH: NIAID PAR-20-178 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) 
  • Sponsor Deadline: Rolling 
  • Discipline/Subject Area: COVID-19
NIH: NIAID PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) ($275,000)

• Sponsor Deadline: Rolling
• Discipline/Subject Area: COVID-19

NIH: NIBIB Point-of-Care Technology Research Network (POCTRN) Fast-Track Program for COVID-19 Test Development and Distribution ($500,000,000)

• Sponsor Deadline: Rolling
• Discipline/Subject Area: COVID-19; Test Development; Diagnostics

American Heart Association: AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact ($100,000)

• Funding Organization’s Deadline: April 6, 2020
• Discipline/Subject Area: COVID-19; Cardiovascular Disease

LifeArc: LifeArc Coronavirus (COVID-19) Therapeutics Development and Testing for Rapid Deployment

• Funding Organization’s Deadline: April 6, 2020
• Discipline/Subject Area: COVID-19, Development and Testing of Therapeutics

NIH: NIAID 2020 Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2020- 1

• Funding Organization’s Deadline: April 9, 2020
• Discipline/Subject Area: COVID-19; Areas of Interest to NIAID

Fast Grants

• Applications are paused due to receipt of a very large number of qualified submissions, Fast Grant applications are currently closed. We may reopen them in the future.